Modulation of the Magnetic Hyperthermia Response Using Different Superparamagnetic Iron Oxide Nanoparticle Morphologies by Reyes Ortega, Felisa et al.
nanomaterials
Article
Modulation of the Magnetic Hyperthermia Response Using
Different Superparamagnetic Iron Oxide
Nanoparticle Morphologies
Felisa Reyes-Ortega 1,2,* , Ángel V. Delgado 1 and Guillermo R. Iglesias 1,*


Citation: Reyes-Ortega, F.; Delgado,




Morphologies. Nanomaterials 2021, 11,
627. https://doi.org/10.3390/nano
11030627
Academic Editor: Vasileios Tzitzios
Received: 26 January 2021
Accepted: 25 February 2021
Published: 3 March 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Department of Applied Physics, University of Granada, 18071 Granada, Spain; adelgado@ugr.es
2 Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía,
University of Córdoba, 14004 Córdoba, Spain
* Correspondence: felisareyes@ugr.es or felisa.reyes@imibic.org (F.R.-O.); iglesias@ugr.es (G.R.I.);
Tel.: +34-957-736-483 (F.R.-O.); +34-958-242-734 (G.R.I.)
Abstract: The use of magnetic nanoparticles in hyperthermia, that is, heating induced by alternating
magnetic fields, is gaining interest as a non-invasive, free of side effects technique that can be
considered as a co-adjuvant of other cancer treatments. Having sufficient control on the field
characteristics, within admissible limits, the focus is presently on the magnetic material. In the
present contribution, no attempt has been made of using other composition than superparamagnetic
iron oxide nanoparticles (SPION), or of applying surface functionalization, which opens a wider range
of choices. We have used a hydrothermal synthesis route that allows preparing SPION nanoparticles
in the 40 nm size range, with spherical, cuboidal or rod-like shapes, by minor changes in the synthesis
steps. The three kinds of particles (an attempt to produce star-shaped colloids yielded hematite)
were demonstrated to have the magnetite (or maghemite) crystallinity. Magnetization cycles showed
virtually no hysteresis and demonstrated the superparamagnetic nature of the particles, cuboidal ones
displaying saturation magnetization comparable to bulk magnetite, followed by rods and spheres.
The three types were used as hyperthermia agents using magnetic fields of 20 kA/m amplitude
and frequency in the range 136–205 kHz. All samples demonstrated to be able to raise the solution
temperature from room values to 45 ◦C in a mere 60 s. Not all of them performed the same way,
though. Cuboidal magnetic nanoparticles (MNPs) displayed the maximum heating power (SAR or
specific absorption rate), ranging in fact among the highest reported with these geometries and raw
magnetite composition.
Keywords: hyperthermia; ILP; magnetic nanoparticles; SPION; nanocubes; nanorods; SAR
1. Introduction
When a suspension of magnetic nanoparticles (with certain geometrical and structural
properties to be discussed below) is subjected to an alternating magnetic field of suitable
strength and frequency, heat is released into the suspending medium, leading to an increase
in temperature. The phenomenon is known as magnetic hyperthermia (MH) and although
biomedical applications were first proposed comparatively recently [1] (previously research
was focused on Joule heating by induced electric fields originated by magnetic fields in
the MHz frequency range [2]), intense heating by alternating magnetic fields applied
to ferromagnetic materials has been used for almost a century [3,4]. The basis of MH
treatment of tumors is the fact that heating the tumor cells in a temperature up to 41–46 ◦C
for a short period of time causes apoptosis without significantly affecting the surrounding
healthy native cells. The main reasons for this finding are related to the fact that the pH
of the intracellular environment is lower in the tumor cells than in the healthy cells, and
this makes the former more sensitive to overheating, and in addition the poor and not
well-organized vascularization of the tumor cell hinders heat dissipation as compared to
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the normal ones [5]. The denaturalization of some cell proteins and its effect on subsequent
activation and deactivation paths has also been mentioned [6,7]. Whatever the exact
mechanism, it is admitted that magnetic hyperthermia allows the local treatment in a
specific site of the body reducing the need for surgery or complementing it, while keeping
the secondary effects of chemotherapy to a minimum.
As a result, MH has demonstrated good in vitro results when used against a wide
variety of cancer cells, either alone [8] or, mainly, in combination with (as coadjuvant of)
other therapies, including chemo- and radiotherapy [9–13]. Specifically, it has been demon-
strated that magnetic hyperthermia improves the anticancer effects of some drugs [14], and
enhances the release of encapsulated antitumor drugs [15–19]. Furthermore, hyperthermia
may favor the immune response via several mechanisms, by enhancing the migration of
immune cells toward the tumor and their toxicity against malignant cells [20]. Although no
similar in vivo efficacy has been demonstrated [14], there are abundant reports regarding
MH (co-)treatment of tumor xenografts in mice [11,15,21–24].
All these examples show that magnetic nanoparticles (MNPs) are potent devices that
can be used as therapeutic tools in oncology, particularly in hyperthermia. In order to
consider the requirements for the MNPs, which can be expected to work best as hyper-
thermia agents, it is necessary to recall the physical bases of hyperthermia. Heat can
evolve in the presence of alternating magnetic fields by eddy currents, but this mecha-
nism can be neglected because of the small dimensions of the MNPs applicable in the
biomedical field. Second, we can think of hysteresis losses related to the area of the hys-
teresis cycle as w = f
∮
BdM, where w is the power dissipated per unit volume, f is the
frequency of the magnetic field B, and M is the material magnetization. The field frequency
must be low enough to avoid tissue heating by eddy currents and significant peripheral
nerves stimulation [25]. Hence, typical values of f are around 105 Hz, but there is safety
limit for the product f ·B when a field is applied to humans; this limit is established in
2π f B ≤ 3800 T/s [26], meaning that the field strength is at most of a few mT. Considering
that the saturation magnetization of SPION is achieved at about 10 kOe (or 1 T in air in
SI units), it is clear that the hysteresis losses can be neglected because we are under the
established limit. However, if the size is such that the particles are magnetic monodomains,
each one will be as a permanent magnet with magnetization parallel to the easy axis [27,28].
When a number of particles are randomly fixed in a rigid matrix, the magnetization will be
negligible, and the flipping between the two orientations of the magnetic moment along
the easy axis at low temperatures will only occur at high strength or high frequency of
an externally applied magnetic field. An approximately square hysteresis cycle can be
expected. This form of magnetic behavior is called superparamagnetism, and the model
described is known as Stoner-Wohlfarth description [27–29]. It is important to consider
these mechanisms, as superparamagnetic nanoparticles have been shown to absorb much
more power at physiologically relevant magnetic fields and frequencies than multi-domain
particles [30].
At finite temperature, the transition between the two orientations can be thermally
produced and the coercive field tends to zero, so that the cycle shows virtually no hys-
teresis, and the magnetization curve looks like that of a paramagnetic material, hence
the denomination of this behavior. The characteristic time needed for such spontaneous
inversion of magnetization (or for reaching equilibrium after application of a step magnetic
field) is called Néel relaxation time, τN , exponentially growing with
(
Ke f f V/kBT
)
[31,32],
where Ke f f is the effective magnetic anisotropy of the particles (approximately equal to
25 kJ/m3 for magnetite [33,34], V is the particle volume, and kBT is the thermal energy. For
instance, for a magnetite sphere 20 nm in diameter, at room temperature, τN ' 7 s [35,36]).
According to the so-called linear response theory, if the field frequency is ≥ 1/τN ≈ 0.1 Hz,
the magnetization of the sample will lag behind the applied field, leading to an imaginary
component, χ′′ , of the magnetic susceptibility, which is in fact equivalent to a finite area
hysteresis cycle. For high frequencies, the magnetic moment will remain in its orientation
and no net magnetization will show up. According to Carrey et al. [28], this simplified
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approach is valid only for low field strengths and highly anisotropic particles. In practical
hyperthermia applications, the particles can be free to rotate under the action of the field
and viscous friction torques. The process is denominated Brownian relaxation, [31,37] and
its characteristic time is τB = 3ηV/kBT, which, for water (viscosity η) amounts to about
7 µs for the magnetite particles referred to above. This opens a window of field frequencies
in the hundreds of kHz range for maximizing the value of χ′′ ; note for such frequencies the
Néel process is irrelevant, and only friction will be ultimately responsible for heating (a
more detailed discussion can be found in Refs. [38,39]).
We can now consider the question of what conditions must MNPs fulfill to be reliable
hyperthermia candidates? In order to show an effective magnetic hyperthermia response,
the MNPs requirements are (in addition to being non-toxic):
• Superparamagnetic behavior. The particles should have zero coercive field, so that
magnetization is only produced by the external field, and no aggregation takes place
in quiescent conditions.
• Appropriate particle size. Ideally, particles should be larger than 15 nm and smaller
than 100 nm. The magnetization of MNPs decreases with decreasing particle size [40].
For a given magnetic material there is an optimum size that will result in enhanced
hyperthermia effects [41], but in general below 15 nm the heating absorption of the
nanoparticles is limited, so it is highly desirable to determine hyperthermia efficiency
of MNPs with mean size ranging above the superparamagnetic limit ≥15 nm). In con-
trast, those above 100 nm are of lesser interest because they display high coercivity and
strong remanence, both undesired. For example, for superparamagnetic MNPs, Vree-
land et al. observed that for an AC excitation field of H0 = 36.5 kA/m and f = 341 kHz,
the optimum size showing maximum rate of release heat was around 22 nm, which
matches the theoretical prediction of the lineal response theory [42,43]. Many authors
have demonstrated that the optimal size for internalization into tumor cells, especially
if these MNPs are used as theranostic agents (intracellular hyperthermia) is below
100 nm [44,45].
• The MNPs must be highly magnetizable. The rate of change of the magnetic energy of
a system under the action of a time varying magnetic field,
.
H, is given by −µM·
.
H,
with µ the magnetic permeability of the medium and M the magnetization [46].
• The suspension of MNPs must be colloidally stable, with low degree of aggregation
or agglomeration. It has been shown that an improvement of stability brings about a
better hyperthermia performance [47,48].
Shape and crystalline anisotropies: the heating efficiency of MNPs shows dependence
with the crystalline and shape anisotropy, which is optimized by developing MNPs with
different morphologies [49]. Along this line, cubic shaped MNPs have been synthesized
because of their higher magnetization compared to the spherical MNPs [50], due to their
reduced surface anisotropy. Song et al. produced and compared the heating performance of
quasi-cubical and spherical Fe3O4 nanoparticles under fields of 100 kHz and 30 kA/m. For
equal concentration of Fe, the heating power was far higher for quasi-cubical particles [51].
Denfeng et al. demonstrated that rod-shaped MNPs can kill cancer cells more effectively
than spherical MNPs when being exposed to AMF [52]. Another study by Nemati et al.
compared deformed cube (octopods) shaped MNPs with spherical nanoparticles of similar
volume and demonstrated superior heating performance of the octopods [53]. The shape
of MNPs can also influence their rate of uptake and toxicity [54]. A recent study of shape
effects has been reported by Mohapatra et al. [55], with very significant findings. They
investigated the hyperthermia performance of spheres, octahedral, cubes, and multipods
sized around 10 nm, together with 25 nm rods and 80 nm wires, all with magnetite
composition. The heating power increased in the order multipods < spheres < cubes <
octahedral < rods < wires, indicating a large effect of shape anisotropy on the hyperthermia
effect of magnetic particles. According to the Stoner-Wohlfarth model, a contribution of
minor hysteresis loops in the case of magnetic wires resulted to be determinant in this case.
In fact, Iacob et al. [56] in a numerical simulation of the heating rate of spheroidal particles
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of different dimensions and axial ratios found that magnetic shape anisotropy can surpass
the magnetocrystalline anisotropy for axial ratios as low as 1.2.
These factors must be considered when designing nanoparticles for clinical applica-
tions. Higher heating efficiency would be desirable, as it would reduce the amount of
nanoparticles, field strength, and frequency required to induce significant heating. Regard-
ing their composition and crystal structure, MNPs are mostly made from ferromagnetic iron
oxides, such as magnetite (Fe3O4) or maghemite (γ-Fe2O3) for biomedical applications [32],
although the former are the most interesting ones, with the additional advantage that they
usually show less toxic effects in the organism [12,57].
As mentioned, the control and modulation of different magnetite nanoparticles in
terms of size and morphology appears very important in order to get potent magnetic
hyperthermia agents for biomedical applications. In this paper it is described an easy
synthetic method that allows obtaining MNPs with different morphologies, by just varying
three simple variables: reaction time, reaction temperature, and solvent. The four different
morphologies obtained show a mean particle size in the range 20–60 nm, which, as detailed
above, is the optimum size range for hyperthermia and tumor cell endocytosis. The
magnetic hyperthermia response for each of the obtained nanoparticle morphologies has
been determined and compared, using magnetic field intensities and frequencies which are
safe for biomedical applications [58].
2. Results and Discussion
2.1. Morphology and Particle Size Distribution
The hydrothermal methods are increasingly used for the preparation of MNPs because
of their versatility in obtaining crystalline particles with controlled size and morphology
in reasonable cost and good yield [59,60]. In the present work, four different nanoparticle
morphologies were obtained using this method: spheres (SP), cubes (CU), rods (RO), and
stars (ST). No significant evidence of aggregation was found from TEM observations for
any of the MNPs dispersed in TMAH aqueous solution (Figure 1). As observed in this
figure, spherical nanoparticles can be easily transformed to cubic morphology by changing
the suspension solvent from hexane to ethyl acetate. Size is not modified significantly
(Figure 2). However, the cubic morphology produces significant changes in the magnetic
and hyperthermia properties of the particles, as will be described below.
Reaction temperature can also affect the particle morphology. The nucleation process
is thermodynamically controlled and can be altered using different temperature reactions
at the beginning (when nucleation process is predominant) and at the end of the reaction.
This temperature change allows the production of rod morphology, keeping the dimension
of the nanoparticles between 20 and 60 nm (Figure 2); specifically, the average sizes (±SD)
were: 22.2 ± 0.1 nm (diameter of SP), 24.1 ± 0.4 nm (size of CU), 27 ± 7 nm (length of rods),
3.6 ± 0.5 nm (width of rods), and 64 ± 11 nm (width of ST).
The preparation of star morphology required changing the solvent, the reaction time,
and the initial molar ratios of reactants (Table 1). Benzyl ether acts as antioxidant, and it is
transformed into benzaldehyde and benzoic acid in the presence of oxygen. As a result,
benzyl ether provides a stronger reductive environment than 1-octanol in the reaction
process. Such environment facilitates the decomposition of Fe(CO)5, and, as a consequence
the nucleation process in benzyl ether occurs earlier and faster than in 1-octanol. The lower
HDA concentration versus OA induced the preferential growth along different directions,
resulting in the formation of the star nanoparticles.
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Table 1. Reaction conditions used in the preparation of magnetite nanoparticles with different morphologies. (HDA:
hexadecylamine; OA: oleic acid; SP: spheres; CU: cubes; RO: rods; ST: stars). CU synthesis was carried out in two steps.
Sample HDA (g) OA (mL) Fe(CO)5(mL) Solvent T (
◦C) t Reaction(h) Morphology
SP 1.2 8 8 1-octanol (32 mL) 300 6 Spheres
CU 1.2 8 8
1st Step: 1-octanol (32 mL)
2nd Step: re-suspended in




RO 1.2 8 8 1-octanol (32 mL) 150 & 300 2 h & 4 h Rods
ST 0.6 8 4 Benzyl ether (16 mL) 300 12 Stars
2.2. X-ray Diffraction
The iron oxide phase of the synthesized nanoparticles was identified from the XRD
pattern, as shown in Figure 3, with peak positions at (line indexes between parentheses)
30.4 (220), 35.8 (311), 37.2 (222), 43.5 (400), 53.9 (422), 57.5 (511), and 63.1 (440), which
are consistent with the standard data for magnetite or maghemite (RRuff data base, ID
R06111157) for samples SP, RO, and CU. Star nanoparticles (ST) were identified as hematite
(α-Fe2O3). Hence these particles will be neglected as possible hyperthermia agents.
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2.3. lectric l rface aracterizatio
e eas re t f t e electro retic ilit as a function of p were car ied
o t as a further test of the purity of the synthesized NPs and particularly that of their
surface, by comparison with the existing literature data [61]. Results were obtained in
TMAH 25%wt aqueous solutions, and they are presented in Figure 4. It can be expected
that nanoparticles will acquire surface charge as a result of the ionization of the adsorbed
TMAH molecules. This is a strong base and the presence of hydroxyl groups associated
to its dissolution produces an increase in the negative charge of SPION [62]. Thus, the
isoelectric point of the investigated MNPs was in the vicinity of pH = 5.5, lower than
that of bare magnetite (pH = 6.5) [63], indicating that the adsorption of OH- leads to the
requirement of more acid conditions for neutralizing the surface.
Nanomaterials 2021, 11, 627 7 of 13
Nanomaterials 2021, 11, x FOR PEER REVIEW 7 of 14 
 
 
surface, by comparison with the existing literature data [61]. Results were obtained in 
TMAH 25%wt aqueous solutions, and they are presented in Figure 4. It can be expected 
that nanoparticles will acquire surface charge as a result of the ionization of the adsorbed 
TMAH molecules. This is a strong base and the presence of hydroxyl groups associated 
to its dissolution produces an increase in the negative charge of SPION [62]. Thus, the 
isoelectric point of the investigated MNPs was in the vicinity of pH = 5.5, lower than that 
of bare magnetite (pH = 6.5) [63], indicating that the adsorption of OH- leads to the re-
quirement of more acid conditions for neutralizing the surface. 
 
Figure 4. Electrophoretic mobility measurements as a function of pH for magnetite nanoparticles 
in TMAH 25%wt aqueous solutions. 
2.4. Magnetization Data 
The magnetization cycles of the three magnetite nanoparticle samples are plotted in 
Figure 5. The magnetization values have been normalized to the total mass of the sample 
and it was observed that for all the samples the magnetization tends to saturate at 120 
kA/m approximately. The low-field details included show that hysteresis is negligible, 
and only spheres show a measurable coercivity, below 5 kA/m. The same can be said 
about remanence: the particles have zero remanent magnetization, except again spheres, 
also below 5 kA/m. It can be said hence that the particles display superparamagnetic be-
havior. Interestingly, nanorods show the maximum saturation magnetization (85 emu/g, 
close to the value corresponding to bulk magnetite, 91 emu/g [64]). In contrast, spheres 
display the minimum saturation magnetization. According to the study of No et al. [50], 
this result can be expected, as the surface anisotropy, that is, the discrepancy between 
surface and bulk atomic spins is larger (about double, in fact) in spherical than in cuboidal 
nanoparticles. Regarding rod-shaped particles, their shape provides the required anisot-
ropy, and Mohapatra et al. [55] also found that octahedral and cubic nanoparticles dis-
played larger magnetic saturations than rods. Other authors have found that the shape 
anisotropy prevents the particles from magnetizing in directions other than the easy axis 
of magnetization, and this is why they found a lower saturation magnetization in rods 
than even in spheres [65,66]. Additionally, it must be mentioned that the fact that the de-
magnetization field is lower for the small than for the large axis, additional easy magnet-
ization axes can be created, favoring magnetization for arbitrary field directions [67]. 
i re . Electro r ti ilit ti l in
TMAH 25%wt aqueous solutions.
2.4. Magnetization Data
The magnetization cycles of the three magnetite nanoparticle samples are plotted
in Figure 5. The magnetization values have been normalized to the total mass of the
sample and it was observed that for all the samples the magnetization tends to saturate at
120 kA/m approximately. The low-field details included show that hysteresis is negligible,
and only spheres show a measurable coercivity, below 5 kA/m. The same can be said about
remanence: the particles have zero remanent magnetization, except again spheres, also
below 5 kA/m. It can be said hence that the particles display superparamagnetic behavior.
Interestingly, nanorods show the maximum saturation magnetization (85 emu/g, close to
the value corresponding to bulk magnetite, 91 emu/g [64]). In contrast, spheres display
the minimum saturation magnetization. According to the study of No et al. [50], this result
can be expected, as the surface anisotropy, that is, the discrepancy between surface and
bulk atomic spins is larger (about double, in fact) in spherical than in cuboidal nanoparti-
cles. Regarding rod-shaped particles, their shape provides the required anisotropy, and
Mohapatra et al. [55] also found that octahedral and cubic nanoparticles displayed larger
magnetic saturations than rods. Other authors have found that the shape anisotropy
prevents the particles from magnetizing in directions other than the easy axis of magneti-
zation, and this is why they found a lower saturation magnetization in rods than even in
spheres [65,66]. Additionally, it must be mentioned that the fact that the demagnetization
field is lower for the small than for the large axis, additional easy magnetization axes can
be created, favoring magnetization for arbitrary field directions [67].
2.5. Hyperthermia Response
Nanospheres, nanocuboids, and nanorods exhibited an intense hyperthermia response
in the range of frequencies tested. These three magnetite morphologies (all at 10 mg/mL)
increase the temperature from 25 to 45 ◦C in a few seconds when the magnetic field is
applied (Figure 6). In general, a higher frequency of the applied magnetic field increases
the specific absorption rate (SAR) of the nanoparticles. The hyperthermia response is
heavily influenced by the morphology of the nanoparticles. Having the same amount
of iron oxide (magnetite nanoparticle concentration) and similar particle sizes, the SAR
values for cuboidal nanoparticles were far superior than those for nanospheres or nanorods
(Figure 7). Considering that shape anisotropy is higher for nanorods than for nanocuboids,
it could be expected to obtain higher hyperthermia response for the former. A recent simu-
lation, where it was compared the achievable hyperthermia response using nanorods and
nanocubes, showed that when the average dimensions are below 60 nm, shape anisotropy
is insufficient to stabilize the particles even at short timescales. Surface anisotropy or
particle–particle interactions make important contributions to Néel heating in magnetic
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hyperthermia applications [68]. These simulated results have been experimentally corrobo-
rated in this paper.
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Both SAR and Intrinsic Loss Power (ILP) have been calculated for the three magnetite
samples and different field frequencies (Figure 7). Previously, it was checked for some
samples that the SAR was linearly dependent on the product H2·f, as expected from the
linear response theory. Note how ILP is indeed roughly independent of frequency in
Figure 7. As observed, nanocuboidal particles showed the highest SAR, and an ILP value
of 3.0 ± 0.2 nHm2/kg, independently of the frequency used to carry out the measurement.
The fact that Keff is maximum for this geometry [55] explains this result, considering that
the size of our particles allows neglecting the possible role of hysteresis. To our knowledge,
this value is the highest found at these frequencies for cubic magnetite nanoparticles,
suggesting that this system is very attractive as a potent hyperthermia agent that can
be applied at low, biomedically safe frequencies (less than 400 kHz). Nanospheres and
nanorods showed similar SAR and ILP values at low frequencies (130–180 kHz), although
at 205 kHz the spherical morphology displayed a noticeable increase in both parameters,
probably due to the already mentioned lack of stabilization of the nanorods.
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3. Materials and Methods
3.1. Materials
All reactants used ercially available: hexadecylamine (HDA) 98% purity,
oleic acid (OA) 99% purity, iron pentacarbonyl, dibenzyl ether 98% purity, ethyl acetate
(99.5% purity), tetramethylammonium hydroxide (TMAH) solution in water (25% wt), and
benzyl ether (98% purity) were purchased from Sigma-Aldrich Saint Louis, MO, USA and
were used as received. Absolute ethanol and n-hexane 99% reagent grade were supplied
by Scharlau, Cham Germany.
3.2. Synthesis of Magnetic Nanoparticles
Magnetite nanoparticles were synthesized using a previously described hydrothermal
method [69], modifying different reaction variables. HDA and OA were mixed in the
amounts an in the solvents indicated (Table 1). The mixtures were heated up to 55 ◦C
and stirred for 30 min. After that, the solution was cool d to room temperature and the
amount of ron pentacarbonyl (Fe(CO)5) al indicated in the Table was added and
magnetic stirring co tinue for 60 min. Then, the solution was trans erred to 160 mL
autoclave with Teflon lining and heated to a determined temperature for a specific time
(Table 1). After reaction in the autoclave, the obtained mixture was cooled down to room
temperature, and a black precipitate was obtained. The product of the hydrothermal
synthesis is separated magnetically from the mother liquor, followed by repeated washing
with ethanol, and finally dried or re-suspended in hexane (SP, RO, and ST). In the case
of the CU sample, a two-step process was followed, starting with the above described
spherical particles in hexane, and exchanging the solvent with ethylacetate, as follows:
10 mL of magnetite/hexane nanoparticle suspension (10 mg/mL) was placed in a round
bottom flask and 50 mL of ethyl acetate was added. This mixed solvent nanoparticle
suspension was sonicated using an ultrasonic probe (Branson Sonifier 450, Danbury, CT,
USA) for 10 min. Finally, the hexane solvent was evaporated under vacuum at 55 ◦C.
3.3. TEM Characterization: Morphology
The morphology of the nanoparticles was analyzed by transmission electron mi-
croscopy (TEM) using a High-Resolution LIBRA 120 Plus Carl Zeiss microscope (Oberkochen,
Germany). TEM images were analyzed with J-Image software (ImageJ2 online version
from University of Wisconsin, Madison, WI, USA) in order to calculate the particle size
distribution of the dried NPs (n > 1000 nanoparticles).
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3.4. X-ray Diffraction Measurements
The crystalline phase was identified by recording X-ray powder diffraction patterns
(XRD) of the dry, washed samples using a Bruker D8 Advance diffractometer (Berlin,
Germany) equipped with a CuKα radiation source (λ = 1.5406 Å) and a Bruker LINXEYE
detector. Analysis was carried out at 25 ◦C, 40 kV and 40 mA. The 2θmeasured range was
20◦–70◦, at 0.02◦ steps, with a measurement time of 576 s/step.
3.5. Electrophoretic Mobility: Isoelectric Point Determination
Electrophoretic mobility measurements were carried out in a Zetasizer Nano-ZS
(Malvern Instruments, Worcestershire, U.K.) at 25 ◦C. Samples were prepared by simply
adding 0.5 mL of MNPs suspensions (10 mg/mL) in TMAH 25%wt solution to 50 mL 5 mM
KNO3 water solution (fixed ionic strength) until finally obtaining a slightly turbid solution
adequate for this type of determination. The pH of the suspensions was then adjusted
by adding a suitable amount of KOH (0.01 or 0.1 M) or HNO3 (0.01 or 0.1 M). For each
suspension, 5 measuring runs were taken, with 11 cycles in each run.
3.6. Magnetic Properties
Magnetization cycles were obtained at room temperature (20 ◦C) in an MPMS-XL
SQUID magnetometer (Quantum Design, San Diego, CA, USA). Between 1 and 3 mg dried
samples were used for these measurements.
3.7. Magnetic Hyperthermia Determinations
The alternating currents necessary to produce the magnetic fields applied to the
samples were produced by a Royer-type oscillator with 8 turn coils (20 mm in diameter and
45 mm in length) made of copper tube 6 mm in diameter, refrigerated with 25 ◦C water. The
magnetic field strength H0 was 16.2 kA/m (measured with a NanoScience Laboratories Ltd.
Probe (UK), with 10 µT resolution) in the center of the coil, where samples were located.
Five frequencies were used, namely 136, 146, 160, 180, and 205 kHz.
For the determination of the heat released by the particles under the action of the field,
0.5 mL suspensions containing 10 mg/mL of each sample were placed in Eppendorf tubes,
thermally isolated, and located in the center of the coil. Temperature T changes vs. time
were registered at 1 Hz sampling rate with an optical fiber thermometer (Optocon AG,
Dresden, Germany) connected to a computer. The experiments were always performed in
samples pre-thermostated at 25 ◦C.
The heating efficiency (as evaluated by the specific absorption rate, SAR) of the
nanoparticles was calculated from the initial slope dT/dt (first 30 s after the magnetic field







where C is the volume specific heat capacity of the sample (CH2O = 4185 J/LK), Vs = 0.5 mL
is the sample volume, and m is the mass of magnetic material (5 mg in the present investi-
gation). As the hyperthermia response is also dependent on the frequency f and strength
H0 of the magnetic field, hence on the particular measuring system used, it is sometimes
preferred to use an intensive, device-independent quantity to describe the hyperthermia ef-
ficiency for a given sample in terms of the so-called intrinsic loss power or ILP [31], typically






Four different morphologies of magnetite nanoparticles have been synthesized us-
ing similar methodologies, obtaining comparable particle sizes. The reaction variables
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such as solvents used, temperature, and duration of reactions influence the shape of the
nanoparticles. The synthesized nanoparticles showed an optimal particle size to be used
as hyperthermia agents. The heating capacities of these superparamagnetic nanoparti-
cles have been characterized and investigated in terms of SAR/ILP. A modulation of
the saturation of magnetization and hyperthermia response were obtained in function
of the morphology of the nanoparticles used. Cuboidal nanoparticles exhibited higher
heating absorption properties and intrinsic loss power than nanospheres or nanorods,
and the highest ILP described in the literature is for nanocubes with the same magnetic
material at these low frequencies. It is suggested that this morphology could be optimum
for hyperthermia using relatively low magnetic field strength and frequency, which is
clinically preferred. These magnetic quasicubic nanoparticles can be a very powerful tool
in biomedical applications.
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